Friday, January 21, 2011
One of the information resources that we provide on the IN-CAM website is a list of research journals that publish research on CAM and Integrative Health Care. As this field of inquiry continues to develop and expand, this list continues to grow.
CAM Journals and Databases list
Determinants of geographic patterns of diseases: interaction of lactose/lactase status and sunshine exposure - Jnl Med Hypotheses
".........The patterns related to sunshine (Vitamin D) reflect that obtained with national lactase status proportions and also corroborate a literature review. However, correlations are weak to moderate and only ovarian cancer reached conventional statistical significance. Because these comparisons are based on modest number of national data firm conclusions cannot be made....."
PLoS Medicine: The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview
abstract: Bleeding events in (Avastin) bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study
These data suggest that bevacizumab did not increase the risk of severe bleeding in cancer patients who received
Lisa Sanders is the author of “Every Patient Tells a Story: Medical Mysteries and the Art of Diagnosis.”
full free access: Preventable adverse drug events and their causes and contributing factors: the analysis of register data — Int J Qual Health Care (patient safety)
"In recent years, the number of patient complaints has also increased, probably because patients are more aware of their rights and more attention has been paid to patient safety . These complaints contain detailed narratives about the case, and these data can be used to understand which factors contribute to errors in health care .
The purpose of this study was to evaluate the nature of preventable ADEs based on data from national supervisory authority. In particular, the study focuses on the potential causes and contributing factors of preventable ADEs from the information management point of view.
The study aims to answer the following questions:
1. What are the causes of ADEs, and in which phase of the medication management process are the causes for ADEs present?
2. How does information management affect the origin of ADEs?
3. What are the contributing factors for ADEs in information management?
Expression of TGFß1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin
Abstract ....... It is suggested that TGFß1 mRNA expression is an indicator of tumor sensitivity to standard therapy with PTX (Taxol) and CBDCA (Carboplatin), that it can identify biologically aggressive and highly malignant tumors and that it can predict the prognosis of patients with ovarian cancer."
Register for our webinar series online! If you've already registered, you'll be sent a reminder the day before this presentation.
The Webinar Series schedule is as follows:
Tuesday, January 25, 2011 at 2:00pm EST
Are Clinical Trials the Answer?
Dr. Ronnie Alvarez, Professor Ob/Gyn, University of Alabama
Thursday, February 10, 2011 at 1:00pm EST
Young Survivors Rock!
Lindsay Avner, Founder and Executive Director, Bright Pink
Chana Garcia, advocate, blogger and ovarian cancer survivor
Thursday, February 17, 2011 at 1:00pm EST
Ovarian Cancer – What’s Basic? What’s New?
Dr. Robert Coleman, Professor, Department of Gynecologic Oncology, MD Anderson Cancer Center
Wednesday, March 2, 2011 at 1:00pm EST
Getting Involved with Partner Members
Robin Cohen, OCNA Board member and Partner Member
Sue Ellen Moore, OCNA Board member and Partner Member
PET/CT was able to detect active disease at relatively low levels of CA125, thereby facilitating the early diagnosis of recurrence or residual disease. Also in patients with low CA125 levels (<30).
This issue of Frontiers is available in print and online (pdf).
To request a printed copy, contact the UT Graduate School of Medicine at 865-305-9190 or click here.
BackgroundHereditary nonpolyposis colorectal cancer (HNPCC), an autosomal-dominant syndrome, accounts for 2-5% of all colorectal carcinomas. Colorectal cancer in patients with hereditary nonpolyposis colorectal cancer (HNPCC) presents at an earlier age than in the general population and is characterized by an increased risk of other cancers, such as endometrial cancer and, to a lesser extent, cancers of the ovary, stomach, small intestine, hepatobiliary tract, pancreas, upper urinary tract, prostrate, brain, and skin.
Table 1. Seven different genes are known to be associated with HNPCC,
and all of them are involved with DNA mismatch repair, identified with
the frequencies below.
|Mismatch Excision Repaired MMR||Chromosome Location||Frequency of HNPCC Cases|
|Other genes not yet discovered|
Incidence of different types of cancers between individuals with Lynch syndrome and those in the general population.
abstract: Health-related quality of life and cancer clinical trials — Therapeutic Advances in Medical Oncology
"The overall outlook for the routine assessment of patient-reported outcomes in clinical trials is assured and, eventually, it is likely to become a standard part of clinical practice. However, there is still a need for a clear method for determining the clinical meaningfulness of changes in scores. The answer will probably come from the greater use of patient-reported outcomes and the consequent growth of experience that is necessary to make such judgements"